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Korean red ginseng and ginsenosides have been claimed to possess wide spectrum of medicinal eﬀects, of which anticancer eﬀect is
one. The present study was undertaken to investigate the antimetastatic eﬀect of Korean red ginseng on human hepatoma as well
as possible mechanisms. The inhibitory eﬀect of the water extract of Korean red ginseng (WKRG) on the invasion and motility of
SK-Hep1 cells was evaluated by the Boyden chamber assay in vitro. Without causing cytotoxicity, WKRG exerted a dose-dependent
inhibitory eﬀect on the invasion and motility, but not adhesion, of highly metastatic SK-Hep1 cells. Zymography analyses revealed
signiﬁcant downregulating eﬀects on MMP-2, MMP-9, and uPA activities in SK-Hep1 cells. Western blot analyses also showed that
WKRG treatment caused dose-dependent decreases in MMP-2 and MMP-9 protein expressions. Moreover, WKRG increased the
levels of TIMP-1, TIMP-2, and PAI-1. The present study not only demonstrated that invasion and motility of cancer cells were
inhibited by WKRG, but also indicated that such eﬀects were likely associated with the decrease in MMP-2/-9 and uPA expressions
of SK-Hep1 cells.
1.Introduction
Hepatocellular carcinoma (HCC) is one of the most com-
mon malignancies in Taiwan. Metastasis is characteristic
of highly malignant cancers with poor clinical outcomes.
Most patients with HCC die within one year after diagnosis
largely because of frequent tumor metastasis [1]. One critical
characteristic of metastatic cancer cells is the ability to dis-
solve basement membranes and extracellular matrix (ECM).
This degradative process is mediated mainly by matrix
metalloproteinases (MMPs), a large family that can degrade
all known components of ECM [2]. MMP-2 and MMP-9
are abundantly expressed in various malignant tumors and
play critical roles in tumor metastasis. Thus, the inhibition
of MMP activity is important in terms of preventing cell
metastasis [3]. Interestingly, MMP-9 expression levels are
especially high in hepatoma cells, such as SK-Hep1 cells, and
the enzyme has been studied in diverse malignant tumors
because of its inducible character [4]. MMP-9 inhibitors
have been developed and are currently being investigated in
clinical trials [5].
Korean red ginseng (Panax ginseng C.A. Meyer) has been
claimed to possess anticancer eﬀects. The major active com-
ponents of ginseng are triterpene saponins, known as gin-
senosides, which are divided into two groups: protopanaxa-
diol type (Rb1 group) and protopanaxatriol type (Rg1
group). Protopanaxadiol-type ginsenosides are metabolized
by human intestinal bacteria to 20-O-β-D-glucopyranosyl-
20(S)-protopanaxadiol (M1, also known as compound K),
which is then absorbed from the gastrointestinal tract [6].
The metabolite has a variety of pharmacological activities
including antitumor, antidiabetic, anti-inﬂammatory, and
antiallergic eﬀects [7]. We have established an in vitro
model of cancer metastasis using SK-Hep1 cells, and showed2 Evidence-Based Complementary and Alternative Medicine
Table 1: Analytical data received from the Korean Ginseng Corpo-
ration on the ginsenoside contents of WKRG and EKRG.
Ginsenoside (mg/g extracts)
Rb1 Rb2 Rg1 Rg3 Rc Rd Re
WKRG 11.79 4.68 6.14 0.44 4.71 1.22 4.71
EKRG 4.03 1.97 0.52 2.89 1.98 1.51 1.18
that the anti-metastatic pathway was associated with the
inhibition of MMP-2, MMP-9, and urokinase plasmino-
gen activator (uPA), as well as the elevated levels of tissue
inhibitor of metalloproteinases (TIMPs) and plasminogen
activator inhibitor (PAI-1). Since Korean red ginseng has
been reported to exhibit anticancer eﬀects, we aimed to eval-
uate the anti-metastatic eﬀects of Korean red ginseng by
using experimental models with SK-Hep1 cells.
2.MaterialsandMethods
2.1. Chemicals. Dulbecco’s modiﬁed Eagle’s medium
(DMEM) and 3-(4,5-dimethylthiazolyl-2)-2,5-diphenyltet-
razolium bromide (MTT) were obtained from Sigma Chem-
ical Co. (St. Louis, MO, USA). Trypsin-EDTA, fetal bovine
serum (FBS), and penicillin/streptomycin were from Gibco
Life Technologies, Inc. (Paisley, UK). Other chemicals were
obtained from Sigma-Aldrich Chemical Co. (St. Louis, MO,
USA). Cell culture supplies were purchased from Costar
(Corning, Inc., Cypress, CA, USA). Anti-MMP-2 (SC-
373914), anti-MMP-9 (SC-10737), and anti-PAI-1 (SC-
6642) mouse monoclonal antibodies were purchased from
Santa Cruz Biotechnology Co. (Santa Cruz, CA, USA).
2.2. Korean Red Ginseng Extracts. Water and ethanolic ex-
tracts of Korean red ginseng (WKRG and EKRG) were
oﬀered by the Korean Society of Ginseng and were stored
underlight protectionbeforetheexperiment. Analyticaldata
on the ginsenoside contents of WKRG and EKRG has also
been received as an accompaniment, as presented in Table 1.
Additionally, it was informed that WKRG was comprised of
61.62% of solids and 36.68% of moisture, and EKRG was
comprised of 61.62% of solids and 38.38% of moisture.
2.3. Cell Culture. Hepatocarcinoma SK-Hep1 cells were pur-
chased from the Bioresources Collection and Research Cen-
ter (BCRC) of the Food Industry Research and Develop-
ment Institute (Hsinchu, Taiwan). Cells were cultured in
plastic dishes containing Dulbecco’s Modiﬁed Eagle Medium
(DMEM) supplemented with 10% fetal bovine serum (FBS)
in a CO2 incubator (5% CO2 in air) at 37◦Ca n ds u b c u l t u r e d
every other day at a dilution of 1:5 using 0.05% trypsin-
0.02% EDTA in Ca2+-, Mg2+-free phosphate-buﬀered saline
(DPBS).
2.4. Cell Viability. SK-Hep1 cells (2 × 105 cellsperwell)were
seeded in a 96-well plate containing DMEM supplemented
with 10% FBS for 1 day to become nearly conﬂuent before
being cultured with various concentrations of WKRG and
EKRG (0, 100, 200, 400, 800, and 1600μg/mL) for 24h.
The cells were then washed twice with DPBS and incubated
with 100μLo f0 . 5 m g / m LM T Tf o r2 ha t3 7 ◦C( M T T ,
(3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bro-
mide). The medium was discarded and 100μL of dimethyl-
sulfoxide (DMSO) was added. After 30min of incubation,
the absorbance was read with a microplate reader at 570nm.
2.5. Determination of MMP-2, MMP-9, and uPA Activities
by Zymography. C e l l sw e r et r e a t e dw i t hd i ﬀerent concentra-
tions (0, 100, 200, and 400μg/mL) of WKRG and EKRG
for 24h. The conditioned media were collected, and MMP-2
andMMP-9activitieswereassayedusinggelatinzymography
(7.5% zymogram gelatin gels) according to the method
reported by Lai et al. with some modiﬁcations which began
with electrophoresing (120V for 90min) the culture media
in a 10% SDS-PAGE gel containing 0.1% gelatin [4]. The
gel was then washed at room temperature in a solution
containing 2.5% (v/v) Triton X-100, subsequently it was
transferred to a reaction buﬀer containing 1% NaN3,1 0m M
CaCl2, and 40mM Tris-HCl for enzymatic reaction at 37◦C
and pH 8.0 before being shaken overnight for 12∼15h. Next
day, the MMP gel was stained with 0.25% (w/v) Coomassie
blue in 10% acetic acid (v/v) and 20% methanol (v/v) for
30min before it was destained in 10% acetic acid (v/v) and
20% methanol (v/v).
VisualizationofuPAactivitywascarriedoutaccordingto
the method reported by Maeda-Yamamoto et al. [8]. Brieﬂy,
2% w/v casein and 20mg/mL plasminogen were added to an
8%SDS-PAGEgel.Sampleseachwithatotalproteinofabout
20μg were loaded onto the gel. The uPA activities of cells
treatedoruntreatedwithWKRGweremeasuredasdescribed
in the gelatin zymography assay. The relative MMP-2, MMP-
9, and uPA activities were quantiﬁed by using Kodak Molec-
ular Imaging Software (Version 4.0.5, Eastman Kodak Com-
pany, Rochester, NY) and represented in relative intensities.
2.6. Cell Migration Assay. T u m o rc e l lm i g r a t i o nw a sa s s a y e d
in transwell chambers (millipore) according to the method
reportedbyHuangetal.withsomemodiﬁcations[9].Brieﬂy,
t r a n s w e l lc h a m b e r sw i t h6 . 5m mp o l y v i n y l / p y r r o l i d o n e - f r e e
polycarbonate ﬁlters of 8μm pore size were used. SK-
Hep1 cells (5 × 105 mL−1) and WKRG (0–400μg/mL) were
suspended in 100μLo fs e r u m - f r e eD M E Mb e f o r eb e i n g
placed in the upper transwell chamber; as for the lower
chamber, 10% FBS-containing medium was placed in as a
chemoattractant. After 24h of incubation at 37◦C, cells on
the upper surface of the ﬁlter were completely wiped away
with a cotton swab, and the lower surface of the ﬁlter was
ﬁxed in methanol, stained with Giemsa and counted under a
microscopeatamagniﬁcationof200x.Foreachreplicate,the
tumor cells in 10 randomly selected ﬁelds were determined,
and the counts were averaged.
2.7. Cell Invasion Assay. The invasion of tumor cells was
assessed in transwell chambers with 6.5mm polycarbonate
ﬁlters of 8μm pore size, as described in the cell migration
assay except that each ﬁlter was coated with 100μLo fEvidence-Based Complementary and Alternative Medicine 3
Matrigel (1:20 dilution in cold DMEM) to form a thin con-
tinuous ﬁlm on the top side of the ﬁlter. Cells were adjusted
to 5 × 105 mL−1, and 100μL (containing 5 × 104 cells)
in DMEM containing 10% FBS was transferred to each of
triplicate wells. After incubating for 24h, the cells were
stainedandcountedasdescribedpreviously,andthenumber
of cells invading the lower side was measured [9].
2.8. Cell Adhesion Assay. Each well of a 24-well tissue culture
plate was coated with 25μg of Matrigel and left to air-
dry for 40min. SK-Hep1 cells (5 × 104) and WKRG (0–
400μg/mL) suspended in DMEM containing 0.5% bovine
serum albumin were then dispensed into each well. The
plate was incubated in 5% CO2 at 37◦C for 1h and then
gently washed thrice with PBS to remove any unattached
cells. Attached cells were then stained with hematoxylin
and eosin reagent before being counted under a microscope
(Eclipse TS100, Nikon, Japan). At least three independent
experiments were performed [9].
2.9. Wound-Healing Assay. For cell motility determination,
SK-Hep1 cells (5 × 104 cells per well) were seeded in a 6-well
tissue culture plate and grown to 80∼90% conﬂuence. After
aspiration of the medium, the center of the cell monolayer
was scraped with a sterile micropipette tip to create a de-
nuded zone (gap) of constant width. Subsequently, cellular
debriswaswashedwithPBS,andSK-Hep1cellswereexposed
to various concentrations of WKRG (0–400μg/mL). Wound
closure was monitored and photographed at 0, 12, and 24h
with a Nikon inverted microscope. To quantify the migrated
cells, pictures of the initial wounded monolayers were
compared with the corresponding pictures of cells at the end
of incubation. Artiﬁcial lines ﬁtting the cutting edges were
drawnonpicturesoftheoriginalwoundsandoverlaidonthe
pictures of cultures after incubation. Cells that had migrated
across the white lines were counted in six random ﬁelds for
each triplicate treatment [3].
2.10. Preparation of Whole-Cell Lysates. SK-Hep1 cells (1 ×
105 cells) were plated in 100mm tissue culture ﬂasks and
treatedwithvariousconcentrationsofWKRG.SK-Hep1cells
were washed twice with PBS and were scraped into micro-
centrifuge tubes. The cells were centrifuged at 1,250g for
5min, and the pellets were lysed with iced-cold RIPA buﬀer
(1% NP-40, 50mM Tris-base, 0.1% SDS, 0.5% deoxycholic
acid, 150mM NaCl, pH 7.5), to which was added freshly pre-
pared phenylmethylsulfonyl ﬂuoride (10mg/mL), leupeptin
(17mg/mL), and sodium orthovanadate (10mg/mL). After
incubating for 5min on ice, the samples were centrifuged at
10,000g for 10min, and the supernatants were collected as
whole-cell lysates. The protein content was determined with
Bio-Rad protein assay reagent using BSA as the standard.
Finally, whole-cell lysate proteins (30–50μgo fp u r i ﬁ e dp r o -
tein) were boiled for 10min in electrophoresis sample buﬀer.
2.11.WesternBlottingAnalysis. Totalcelllysatesofequalpro-



































Figure 1: Viability of SK-Hep1 cells incubated with WKRG and
EKRG(0,100,200,400,800,and1600μg/mL)for24h.Cellviability
wasmeasuredusingMTTassayandisexpressedas%ofcellsurvival
relative to the control. Values are expressed as means ± SD of three
independentexperiments. ∗P<0.05, ∗∗P<0.01,and ∗∗∗P<0.001
as compared with the untreated control.
then transferred onto nitrocellulose membranes (Millipore,
Bedford, MA) by electroblotting (Bio-Rad). Nonspeciﬁc
binding of the membranes was blocked with Tris-buﬀered
saline (TBS) containing 1% (w/v) nonfat dry milk and 0.1%
(v/v) Tween-20 (TBST) for more than 2h. Membranes were
washedwithTBSTfor10minthreetimesandthenincubated
with an appropriate dilution of speciﬁc primary antibodies
in TBST overnight at 4◦C. The membranes were washed
with TBST before being incubated with an appropriate set
of secondary antibody (horseradish peroxidase-conjugated
goat anti-mouse or anti-rabbit IgG) for 1h. After washing
the membrane for 10min three times in TBST, the bands
were visualized using ECL reagent (Millipore, Billerica, MA).
Band intensity on scanned ﬁlms was quantiﬁed using Kodak
Molecular imaging (MI) software and expressed as relative
intensity compared with the control.
2.12. Statistical Analysis. Values were expressed as means ±
SD and analyzed using one-way ANOVA followed by Tukey’s
Test for comparison of group means. All statistical analyses
were performed using SPSS for Windows, version 10 (SPSS,
Inc.). P values < 0.05 were considered statistically signiﬁcant.
3. Results
3.1. Cytotoxicity of Korean Red Ginseng Extracts. In the ﬁrst
part of this study, we examined the cytotoxicity of WKRG
and EKRG by treating SK-Hep1 cells at various concen-
trations (0, 100, 200, 400, 800, and 1,600μg/mL) for 24h
followed by MTT assay. In Figure 1, it is shown that WKRG
treatment at the concentration of 0–400μg/mL and EKRG




























































Figure 2: (a): Eﬀects of WKRG and EKRG on MMP-2 and MMP-9
activities of SK-Hep1 cells. Cells were treated with various concen-
trations (0, 100, 200 and 400μg/mL) of WKRG and EKRG for 24h.
The conditioned media were collected, and MMP-2 and MMP-9
activities were determined by gelatin zymography. (b) MMP-2 and
MMP-9 activities were quantiﬁed by densitometric analyses. Values
are expressed as means ± SD of three independent experiments.
∗P<0.05, ∗∗P<0.01, and ∗∗∗P<0.001 as compared with the
untreated control.
cytotoxicity against SK-Hep1 cells after 24h. In all subse-
quent experiments, only doses below or equal to 400μg/mL
were applied.
3.2. Inhibition of MMP-2 and MMP-9 Activities by WKRG
and EKRG. Metastasis has been found to be accompanied by
various physiological alterations involved in the degradation
of ECM, including overexpression of proteolytic enzyme
a c t i vi t i e s ,s u c ha sM M P so ru P A ,a sw e l la st h em i gr a t i o na n d
invasion of tumor cells into the bloodstream or lymphatic
system to spread to other tissues or organs. To investigate
whether WKRG and EKRG could inhibit matrix-degrading
proteinases, the conditioned media were collected after SK-
Hep1 cells had been treated with WKRG and EKRG for
24h. As shown in Figure 2(a), WKRG inhibited MMP-9
andMMP-2activitiesinaconcentration-dependentmanner,
with 62.6% and 81.5% inhibitions at 400μg/mL after 24h of
incubation (Figure 2(b)), respectively. However, EKRG had
no signiﬁcant inhibition on MMP-9 and MMP-2 activities


































Figure 3: (a): Eﬀect of WKRG on uPA activity of SK-Hep1 cells.
Cells were incubated in the presence or absence of WKRG for 24h.
The conditioned media were collected, and uPA activity was deter-
mined by casein zymography. (b) uPA activity was quantiﬁed by
densitometric analysis. Values are expressed as means ± SD of
three independent experiments. ∗∗P<0.01 and ∗∗∗P<0.001 as
compared with the untreated control.
(Figure 2(a)). Based on the above observation, we used
WKRG to do the following experiments in this paper.
3.3. Inhibition of uPA Activity by WKRG. As shown in
Figure 3(a), uPA activity was also inhibited in a concentra-
tion-dependent manner by WKRG treatment, with 56.6%
inhibition at the dosage of 400μg/mL after incubating for
24h (Figure 3(b)).
3.4. Inhibition of Migration, Invasion, and Adhesion by
WKRG. The inhibitory eﬀects of WKRG on the migration
and invasion of SK-Hep1 cells were evaluated by the Boyden
chamber assay in vitro. We found that WKRG at the con-
centrations of 0–400μg/mL obviously decreased both the
migration and invasion (Figures 4(a) and 4(b))o fS K - H e p 1
cells dose-dependently. IC50 values for migration and inva-
sionofWKRGwereapproximately282.83and135.15μg/mL,
respectively. Since cell-matrix interaction is important for
cancer cell invasion, cell-matrix adhesion assay was also
performed. The results revealed that WKRG only caused a
slight reduction in cell adhesion even at the concentration of




















































































































Figure 4: Eﬀect of WKRG on (a) transwell migration, (b) invasion, and (c) adhesion of SK-Hep1 cells. Values are expressed as means ± SD
of three independent experiments. ∗P<0.05, ∗∗P<0.01, and ∗∗∗P<0.001 as compared with the untreated control.6 Evidence-Based Complementary and Alternative Medicine































































Figure 5: Eﬀect of WKRG on wound healing migration of SK-
Hep1 cells. Wound was introduced by scraping the conﬂuent cell
monolayerwithapipettetip.(a)RepresentativephotographsofSK-
Hep1 cells that received either control or WKRG treatments (0, 100,
200,and400μg/mL)for 0,12and24h.(b)Migratedcells across the
black lines were counted in six random ﬁelds for each treatment.
Quantitative assessment of the number of cells in the denuded zone
is expressed as the mean ± SD of three independent experiments.
∗P<0.05, ∗∗P<0.01, and ∗∗∗P<0.001 as compared with the
untreated control.
3.5. Eﬀect of WKRG on Wound Healing. We further assessed
the eﬀect of WKRG on SK-Hep1 cell motility using the
wound healing assay, in which the conﬂuent cell monolayer
was scraped with a sterile micropipette tip to create a
scratch wound. As shown in Figure 5(a), WKRG inhibited
the motility of SK-Hep1 cells in a dose-dependent manner,
with 65.24% and 70.03% reductions at 400μg/mL after
incubating for 12 and 24h, respectively (Figure 5(b)).
3.6. Eﬀect of WKRG on MMP-2/-9, TIMP-1/-2, and PAI-1
Protein Expressions. To further explore the mechanisms be-
hind anti-metastatic eﬀect of WKRG, we determined MMP-
2, MMP-9, TIMP-1, TIMP-2, and PAI-1 protein levels. As
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Figure 6: Eﬀect of WKRG on MMP-2, MMP-9, PAI-1, TIMP-1,
and TIMP-2 protein levels. SK-Hep1 cells were treated with WKRG
(0,100,200,and400μg/mL)for24h,andcelllysatesweresubjected
to SDS-PAGE followed by Western blotting. Levels of these proteins
were subsequently quantiﬁed by densitometric analyses, with the
control set to 100%.
shown in Figure 6, signiﬁcant reductions in MMP-2 (0.43-
fold of control) and MMP-9 (0.34-fold of control) protein
levelswereobservedinSK-Hep1cellstreatedwith400μg/mL
of WKRG. Conversely, WKRG strongly increased TIMP-1
and TIMP-2 protein levels concentration dependently, with
1.89- and 2.13-fold increases at 400μg/mL of treatment,
respectively. In addition, WKRG increased the protein level




red ginseng in human hepatoma SK-Hep1 cells. Analytical
data received from the Korean Ginseng Corporation showed
that there was a great variation in ginsenoside contents
between WKRG and EKRG, most likely due to the diﬀerent
extracting processes. Although the diﬀerence in the eﬀect
of these two extracts on cell viability was not prominent,
there was a great variation in their inhibitory eﬀects on
MMP-2/-9 activities. WKRG inhibited MMP-2/-9 activities
in a concentration-dependent manner, while EKRG had no
signiﬁcant inhibition on MMP-2/-9 activities at all tested
concentrations. Based on the above observation, WKRG was
selected to do the follow-up experiments in this paper. We
found that WKRG also diminished uPA activity of SK-Hep1
cells. Moreover, WKRG signiﬁcantly inhibited the invasion
(assessedusingthetranswellassay)andmigration(examined
by both transwell and wound-healing assays) of SK-Hep1
cells.WefurtherdemonstratedthatWKRGnotablyinhibited
theproteinexpressionsofMMP-2andMMP-9andincreased
the protein levels of TIMP-1, TIMP-2 and PAI-1. These
results indicated that antimetastatic eﬀect of WKRG was
related to the inhibition of enzymatically degradative pro-
cesses of tumor metastasis. To our knowledge, this is the ﬁrst
study that attempted to explore biochemical mechanismsEvidence-Based Complementary and Alternative Medicine 7
underlyingWKRG’sinhibitoryeﬀectonthemetastasisofSK-
Hep1 cells.
Panax ginseng is an herb frequently used in traditional
oriental medicine for its wide spectrum of medicinal eﬀects
such as tonic, immunomodulatory, anticancer, adaptogenic,
antiaging, antioxidant, and neuroprotective eﬀects [10]. The
major active components of ginseng are ginsenosides. More
than forty ginsenosides have, so far, been isolated and each
ginsenoside possesses diﬀerent pharmacological eﬀects [11].
Commercially available Korean ginseng products are classi-
ﬁedintofreshginseng,whiteginseng,andredginseng.White
ginseng is fresh ginseng which has been air-dried, while red
ginseng is obtained by heating. Although processed diﬀer-
ently, both red and white ginseng products are manufactured
from 6-year-old fresh ginseng roots; nevertheless Korean red
ginseng has higher contents of ginsenosides such as Rh2,
Rg3,a n dR g 5 in comparison to white ginseng [12]. Rh2
is produced from ginsenoside Rg3 through bacterial trans-
formation and belongs to the protopanaxadiol family. Rh2
has attracted considerable attention owing to its potential
tumor-inhibitory activity. It constrains cell growth in MCF-7
humanbreastcancerandSK-Hep1hepatomaandcaninduce
apoptosis in various cell lines [13]. Ginsenoside Rg3 has
been reported to reduce the gelatinolytic activities of MMP-
2a n dM M P - 9[ 14]. Other important ginseng saponins with
unique chemopreventive actions include Rb2 which may
partly contribute to the inhibition of lung tumor metastasis
by arresting tumor-associated angiogenesis [15], and Rp1 (a
semisynthesized derivative of ginsenoside Rg5) whose anti-
cancer eﬀect is believed to be achieved by strongly inhibiting
tumor cell metastasis and viability, presumably through
impeding adhesion and vessel formation [16].
Cellmigrationisacomplexprocessinvolvingmanytypes
of intracellular and extracellular components and is associ-
ated with signaling pathways. Since migration is a critical
event in cancer progression and especially in metastasis, the
inhibitory eﬀect of WKRG on cell migration was evaluated
[4]. We found that WKRG signiﬁcantly inhibited the migra-
tion and invasion of SK-Hep1 human hepatoma cells. Inva-
sion of cancer cells through a coated membrane involves not
only ECM degradation, but also the formation of adhesive
interactions between cells and the matrix. Therefore, the cell
adhesion assay was carried out; however we arrived with
the result that WKRG only caused a small reduction in cell
adhesion.Theslightreductioninadhesionmaybeassociated
with the signiﬁcant decreases in migration and invasion by
WKRG treatment.
MMPs belong to a family of zinc-dependent endopep-
tides. They are secreted as inactive proenzymes and are acti-
vated by partial proteolytic cleavage. MMP-2, MMP-9 and
dominant MMPs are released by most endothelial cells and
appear to play important roles in the degradation of type
VI collage, a major constituent of basement membrane, in
cancer invasion and metastasis [17]. In this study, we ob-
served up to 62.6% and 81.5% downregulations of MMP-
2 and MMP-9 activities by WKRG as compared with the
control. Although these are not direct inhibitions of enzy-
matic activity, they seem to be enough to decrease cancer
metastasis, based on other studies [18].
The expression of uPA has been suggested to play a
critical role in local ﬁbrin deposition/dissolution [17]. Con-
version of plasminogen into active plasmin by plasminogen
a c t i v a t o r s ,s u c ha su P A ,i sp r i m a r yf o rﬁ b r i n o l y s i st o
occur. Plasmin degrades ﬁbrin and prevents its extracellu-
lar deposition. WKRG caused a reduction in cell surface
plasmin activity as evidenced by the uPA activity assay. The
importance of ﬁbrinolytic system in wound healing has
been demonstrated in plasminogen-deﬁcient mouse models,
where healing is weakened primarily due to impaired ﬁb-
rinolysis, a consequence of insuﬃcient plasmin generation
[19]. Furthermore, uPA plays prominent roles in cellular
migration and is vital during the initial phases of wound
healing [20]. We used the wound healing assay in vitro to
observe the eﬀect of WKRG on cellular migration. WKRG
potentlyretardedthemigrationofcellstowardsthewounded
area. The results of this study demonstrated that WKRG
inhibited ﬁbrinolysis and cell migration which are vital
during the early phase of wound healing.
To further explore the mechanisms underlying the anti-
metastatic eﬀect of WKRG, we detected the alteration in
levels of several proteins by lysing SK-Hep1 cells after they
had been incubated in the presence or absence of WKRG,
including MMP-2, MMP-9, TIMP-1, TIMP-2, and PAI-1.
There is in vitro evidence that MMPs and TIMPs are critical
in determining the invasive potential of proliferating tumor
cells. MMP-2 and MMP-9 are necessary for the migration
of many normal cell types and tumor cells [21]; on the
other hand, TIMPs are believed to play important roles in
the inhibition of growth and migration, especially in hep-
atocellular carcinomas [22]. These documented ﬁndings
strongly suggest anti-metastatic potential of WKRG, as we
have demonstrated that WKRG suppressed MMP-2/-9 and
enhanced TIMP-1/-2 expressions in terms of protein levels.
PAI-1 is a serine protease inhibitor which inactivates uPA
to prevent it from binding to the uPA receptor (uPAR).
uPAR is part of the plasminogen activation system which is
also involved in the regulation of cell adhesion, migration,
and invasion. It can transmit uPA-mediated extracellular
signals inside the cell, probably through the association with
diﬀerenttypesofintegrinsandECMcomponents.ThusPAI-
1 has the ability to arrest the proteolysis cascade following
uPAR activation [23]. Our experiment by Western blot dem-
onstrated that the protein level of PAI-1 was enhanced in a
dose-dependent manner by WKRG treatment. In summary
of the above results, it is suggested that WKRG’s inﬂuences
on MMP-2, MMP-9, uPA, PAI-1, TIMP-1, and TIMP-2
expressions may have a synergic suppressive eﬀect on the
migration and invasion of tumor cells.
In conclusion, we explored the anti-metastatic eﬀects
and mechanistic actions of WKRG in human hepatoma SK-
Hep1 cells. It was found that WKRG signiﬁcantly inhibited
the invasion and migration of SK-Hep1 cells. Then, we
carried forward the study by showing that WKRG notably
inhibited the expressions of MMP-2, MMP-9, and uPA and
elevated the protein levels of PAI-1, TIMP-1, and TIMP-
2. These results not only evidenced anti-metastatic eﬀect
of WKRG but also showed that such eﬀect was associated
with the inhibition of enzymatically degradative processes of8 Evidence-Based Complementary and Alternative Medicine
tumormetastasis.ThepresentstudysuggeststhatKoreanred
ginseng may be developed into a promising agent for cancer
therapy.Astowhichginsenosidesarepredominantlyrespon-
sible for the anti-metastatic eﬀect of Korean red ginseng
remain primarily unclear and would require further studies.
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